Cano Health, Inc.
CANO · NYSE
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $1 | $2 | $2 | $2 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 2.8% | -11.6% | 27.4% | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | 2% | -7.8% | 10.4% | 15.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -55.3% | -28.6% | -1.1% | -0.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -33.1% | -18.4% | -3.2% | -44.3% |
| EPS Diluted | -49.35 | -26.67 | -5.59 | -61.7 |
| % Growth | -85% | -377.1% | 90.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |